138 related articles for article (PubMed ID: 16720348)
1. Uridine phosphorylase in breast cancer: a new prognostic factor?
Yan R; Wan L; Pizzorno G; Cao D
Front Biosci; 2006 Sep; 11():2759-66. PubMed ID: 16720348
[TBL] [Abstract][Full Text] [Related]
2. Uridine phosophorylase: an important enzyme in pyrimidine metabolism and fluoropyrimidine activation.
Cao D; Pizzorno G
Drugs Today (Barc); 2004 May; 40(5):431-43. PubMed ID: 15319798
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity.
Cao D; Ziemba A; McCabe J; Yan R; Wan L; Kim B; Gach M; Flynn S; Pizzorno G
Mol Cancer Ther; 2011 Dec; 10(12):2330-9. PubMed ID: 21954436
[TBL] [Abstract][Full Text] [Related]
4. Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.
Cao D; Russell RL; Zhang D; Leffert JJ; Pizzorno G
Cancer Res; 2002 Apr; 62(8):2313-7. PubMed ID: 11956089
[TBL] [Abstract][Full Text] [Related]
5. Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5'-deoxy-5-fluorouridine in breast cancer cells.
Wan L; Cao D; Zeng J; Yan R; Pizzorno G
Mol Pharmacol; 2006 Apr; 69(4):1389-95. PubMed ID: 16397116
[TBL] [Abstract][Full Text] [Related]
6. [Doxifluridine for treatment of colorectal cancer].
Nishimura G; Miwa K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():345-8. PubMed ID: 14574909
[No Abstract] [Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma coactivator-1alpha enhances antiproliferative activity of 5'-deoxy-5-fluorouridine in cancer cells through induction of uridine phosphorylase.
Kong X; Fan H; Liu X; Wang R; Liang J; Gupta N; Chen Y; Fang F; Chang Y
Mol Pharmacol; 2009 Oct; 76(4):854-60. PubMed ID: 19602572
[TBL] [Abstract][Full Text] [Related]
8. Expression of uridine and thymidine phosphorylase genes in human breast carcinoma.
Kanzaki A; Takebayashi Y; Bando H; Eliason JF; Watanabe Si S; Miyashita H; Fukumoto M; Toi M; Uchida T
Int J Cancer; 2002 Feb; 97(5):631-5. PubMed ID: 11807789
[TBL] [Abstract][Full Text] [Related]
9. Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors.
Liu M; Cao D; Russell R; Handschumacher RE; Pizzorno G
Cancer Res; 1998 Dec; 58(23):5418-24. PubMed ID: 9850074
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities in uridine homeostatic regulation and pyrimidine nucleotide metabolism as a consequence of the deletion of the uridine phosphorylase gene.
Cao D; Leffert JJ; McCabe J; Kim B; Pizzorno G
J Biol Chem; 2005 Jun; 280(22):21169-75. PubMed ID: 15772079
[TBL] [Abstract][Full Text] [Related]
11. Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update.
Pizzorno G; Cao D; Leffert JJ; Russell RL; Zhang D; Handschumacher RE
Biochim Biophys Acta; 2002 Jul; 1587(2-3):133-44. PubMed ID: 12084455
[TBL] [Abstract][Full Text] [Related]
12. Fluoropyrimidine sensitivity of human MCF-7 breast cancer cells stably transfected with human uridine phosphorylase.
Cuq P; Rouquet C; Evrard A; Ciccolini J; Vian L; Cano JP
Br J Cancer; 2001 Jun; 84(12):1677-80. PubMed ID: 11401323
[TBL] [Abstract][Full Text] [Related]
13. Penetration of capecitabine and its metabolites into malignant and healthy tissue of patients with advanced breast cancer.
Mader RM; Schrolnberger C; Rizovski B; Brunner M; Wenzel C; Locker G; Eichler HG; Mueller M; Steger GG
Int J Clin Pharmacol Ther; 2002 Dec; 40(12):571-2. PubMed ID: 12503818
[No Abstract] [Full Text] [Related]
14. Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes.
Yasuno H; Kurasawa M; Yanagisawa M; Sato Y; Harada N; Mori K
Oncol Rep; 2013 Feb; 29(2):451-8. PubMed ID: 23229803
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel human uridine phosphorylase.
Johansson M
Biochem Biophys Res Commun; 2003 Jul; 307(1):41-6. PubMed ID: 12849978
[TBL] [Abstract][Full Text] [Related]
16. p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction.
Zhang D; Cao D; Russell R; Pizzorno G
Cancer Res; 2001 Sep; 61(18):6899-905. PubMed ID: 11559567
[TBL] [Abstract][Full Text] [Related]
17. Activation of Stat1, IRF-1, and NF-kappaB is required for the induction of uridine phosphorylase by tumor necrosis factor-alpha and interferon-gamma.
Wan L; Cao D; Zeng J; Ziemba A; Pizzorno G
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):488-503. PubMed ID: 20544543
[TBL] [Abstract][Full Text] [Related]
18. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.
el Kouni MH; el Kouni MM; Naguib FN
Cancer Res; 1993 Aug; 53(16):3687-93. PubMed ID: 8339277
[TBL] [Abstract][Full Text] [Related]
19. The significance of thymidine phosphorylase expression in colorectal cancer.
Katsumata K; Sumi T; Yamashita S; Takahashi S; Mori M; Baba T; Murohashi T; Nagashima K; Ashizawa T; Yamamoto K; Koyanagi Y; Katoh K
Oncol Rep; 2001; 8(1):127-30. PubMed ID: 11115583
[TBL] [Abstract][Full Text] [Related]
20. Role of uridine phosphorylase in the anabolism of 5-fluorouracil.
Schwartz PM; Moir RD; Hyde CM; Turek PJ; Handschumacher RE
Biochem Pharmacol; 1985 Oct; 34(19):3585-9. PubMed ID: 2996553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
